Opioid drugmakers Insys Therapeutics and Mallinckrodt Pharmaceuticals face millions of dollars in settlement as a consequence of allegedly bribing doctors to prescribe their drugs.
The US Food and Drug Administration (FDA) issued a warning letter to stem cell clinics about releasing unproven treatments which posed high health risks to patients.
Colorado passed a law requiring drug manufacturers to disclose the wholesale acquisition cost to prescribers in its effort to address the high cost of prescription drugs.
The recent FDA hearing raised the the marketing of recreational CBD as a medical product--an act which falls in violation of federal and state laws. This hearing was well attended by companies and individuals with invested interest in pushing their...
The FDA recently went after VIVUS, a pharmaceutical company, for making false health claims about its product. Inappropriate drug promotions can pose serious issues for pharmaceutical companies that go beyond superficial penalties--companies can...
Popular social posts are spreading the word that interested parties can access research articles directly from the authors without paying the subscription fees that most academic journals or other publishers charge. This idea has implications for...